バイオシミラー成長ホルモンの世界市場レポート 2025年

バイオシミラー成長ホルモン市場規模は、今後数年間で力強い成長が見込まれます。2029年には11億9,000万米ドルに成長し、CAGRは9.8%となります。予測期間の成長は、小児成長障害、適応症の拡大、診断の増加、バイオシミラー選択肢の認知度向上に起因すると考えられます。予測期間における主な動向には、小児に特化したバイオシミラー、バイオシミラーの併用、投与利便性、バイオシミラーの併用、投与利便性などがあります。

小児における成長ホルモン欠乏症の罹患率の上昇が、世界のバイオシミラー成長ホルモン市場の拡大を後押ししています。この欠乏症は、下垂体や視床下部の損傷に起因するもので、生前に存在する先天的な異常から生じる場合もあれば、出生中または出生後に生じる問題（後天的なもの）から生じる場合もあります。例えば、内分泌関連疾患を専門とするオーストラリア内分泌学会（ESA）の支部であるホルモン・オーストラリアが2023年9月に発表したデータによると、成長ホルモン欠乏症は1万人に約2～3人が罹患すると推定されています。その結果、成長不全に罹患する子供の増加が、バイオシミラー成長ホルモン業界の需要を牽引しています。

慢性疾患の有病率の上昇は、バイオシミラー成長ホルモン市場の成長を促進すると予想されています。慢性疾患は、通常は治癒不可能だが効果的に管理できる持続的な健康問題です。このような永続的な疾患は、治すことはできないもの、慢性疾患、特に成長障害や慢性腎臓病の子どもたちの治療に有効であることが示されているバイオシミラー成長ホルモンの使用による管理から恩恵を受けることができます。例えば、2024年2月、米国の公衆衛生機関である疾病対策予防センター（CDC）は、複数の慢性疾患を抱える米国人が増加しており、42％が2つ以上の疾患を管理し、12％が5つ以上の疾患に対処していると報告しています。したがって、慢性疾患の有病率の増加は、今後数年間でバイオシミラー成長ホルモン市場をさらに押し上げると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界バイオシミラー成長ホルモンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のバイオシミラー成長ホルモン市場：成長率分析
• 世界のバイオシミラー成長ホルモン市場の実績：規模と成長, 2019-2024
• 世界のバイオシミラー成長ホルモン市場の予測：規模と成長, 2024-2029, 2034F
• 世界バイオシミラー成長ホルモン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のバイオシミラー成長ホルモン市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 静脈内
• 皮下
• 筋肉内
• オーラル
• 世界のバイオシミラー成長ホルモン市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 成長ホルモン欠乏症
• ターナー症候群
• 特発性低身長
• プラダー・ウィリー症候群
• その他の用途
• 世界のバイオシミラー成長ホルモン市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と薬局
• オンライン薬局/eファーマシー
• 専門クリニック
• 世界のバイオシミラー成長ホルモン市場静脈内注射のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院ベースの管理
• 外来診療所
• 世界のバイオシミラー成長ホルモン市場皮下のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自己管理
• 専門的な管理
• 世界のバイオシミラー成長ホルモン市場、筋肉内注射のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小児科
• 成人ケア
• 世界のバイオシミラー成長ホルモン市場、口腔のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• タブレット
• カプセル

第7章 地域別・国別分析

• 世界のバイオシミラー成長ホルモン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のバイオシミラー成長ホルモン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• バイオシミラー成長ホルモン市場：競合情勢
• バイオシミラー成長ホルモン市場：企業プロファイル
  • Amega Biotech Overview, Products and Services, Strategy and Financial Analysis
  • Biosidus S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • Ferring Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
  • Genetech Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Merck & Co. Inc.
• Novartis AG
• Novo Nordisk A/S
• Sanofi S.A.
• USV Private Limited
• Zhongshan Hygene Biopharm Co. Ltd.
• Biopartners And LG Chem
• Boehringer Ingelheim International GmbH
• Celltrion Inc.
• Coherus BioSciences Inc.
• Daiichi Sankyo Company Ltd.
• Dr. Reddy's Laboratories Ltd.
• Gedeon Richter Plc.
• Genor Biopharma Co. Ltd.
• GenScript Biotech Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• バイオシミラー成長ホルモン市場2029：新たな機会を提供する国
• バイオシミラー成長ホルモン市場2029：新たな機会を提供するセグメント
• バイオシミラー成長ホルモン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Biosimilar growth hormone is a peptide hormone vital for stimulating cellular regeneration, cell division, and overall growth in humans and other organisms. Its significance lies in its role in advancing human development, serving as a targeted mitogen affecting specific cell types.

These hormones are administered through various routes such as intravenous, subcutaneous, intramuscular, and oral methods. Intravenous administration involves the injection of fluids, medications, or nutrients directly into a patient's vein. Applications for biosimilar growth hormones encompass treating conditions like growth hormone deficiency, Turner syndrome, idiopathic short stature, Prader-Willi syndrome, among others. These treatments are available through diverse distribution channels including hospital and retail pharmacies, online pharmacy platforms, and specialty clinics.

The biosimilar growth hormone market research report is one of a series of new reports from The Business Research Company that provides biosimilar growth hormone market statistics, including biosimilar growth hormone industry global market size, regional shares, competitors with a biosimilar growth hormone market share, detailed biosimilar growth hormone market segments, market trends and opportunities, and any further data you may need to thrive in the biosimilar growth hormone industry. This biosimilar growth hormone market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biosimilar growth hormones market size has grown strongly in recent years. It will grow from $0.76 billion in 2024 to $0.82 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to rising demand for growth hormones, patent expirations, clinical evidence, and increasing clinical trials.

The biosimilar growth hormones market size is expected to see strong growth in the next few years. It will grow to $1.19 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to pediatric growth disorders, expanding indications, increase in the diagnosis, and increased awareness of biosimilar options. Major trends in the forecast period include pediatric-focused biosimilars, biosimilar combinations, dosing convenience, biosimilar combinations, and dosing convenience.

The rising incidence of growth hormone deficiency among children is propelling the expansion of the global biosimilar growth hormone market. This deficiency results from damage to the pituitary gland or hypothalamus, which may stem from a congenital abnormality present before birth or an issue that arises during or after birth (acquired). For example, data released in September 2023 by Hormones Australia, a branch of the Endocrine Society of Australia (ESA) specializing in endocrine-related diseases, estimates that growth hormone deficiency affects approximately 2 to 3 in every 10,000 people. Consequently, the increase in children affected by growth deficiencies is driving demand within the biosimilar growth hormone industry.

The rising prevalence of chronic diseases is anticipated to drive the growth of the biosimilar growth hormone market. Chronic diseases are persistent health issues that are usually incurable but can be managed effectively. These enduring conditions, while not curable, can benefit from management through the use of biosimilar growth hormones, which have shown effectiveness in treating chronic illnesses, particularly in children with growth disorders and chronic kidney disease. For example, in February 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based public health organization, reported an increase in Americans living with multiple chronic conditions, with 42% managing two or more conditions and 12% dealing with five or more. Thus, the growing prevalence of chronic diseases is expected to further boost the biosimilar growth hormone market in the coming years.

Leading companies in the biosimilar growth hormones market are developing innovative solutions, such as human growth hormone treatments, to improve the effectiveness and affordability of therapies for growth hormone deficiencies. Growth hormone solutions encompass medical treatments or supplements aimed at stimulating or replacing human growth hormone (HGH) in the body, addressing growth deficiencies and, in some cases, anti-aging needs. For example, in June 2023, Pfizer Inc., a U.S.-based pharmaceutical company, and OPKO Health Inc., a healthcare company also based in the U.S., received approval from the U.S. Food and Drug Administration (FDA) for NGENLA (somatrogon-ghla). This once-weekly injectable growth hormone treatment is designed for pediatric patients with growth hormone deficiency (GHD), offering a long-acting alternative to daily injections that can improve adherence and convenience for both patients and caregivers. The FDA's approval, based on clinical studies showing its safety and efficacy, represents a significant advancement in growth hormone therapy.

Leading companies in the biosimilar growth hormones market are introducing new products, such as growth hormone therapies, to enhance profitability in the industry. Growth hormone therapy involves treatments that supplement or stimulate growth hormone production to aid growth and development, especially in children with hormone deficiencies. For example, in September 2023, Ascendis Pharma A/S, a Denmark-based pharmaceutical company, launched SKYTROFA (lonapegsomatropin) in Germany. Approved for use across the European Union, this once-weekly treatment is designed for children and adolescents aged 3 to 18 years who experience growth failure due to insufficient natural growth hormone production (growth hormone deficiency, or GHD).

In October 2023, the US-based biotechnology company Amgen completed the acquisition of Horizon Therapeutics plc for a substantial $27.8 billion. This strategic move aligns with Amgen's overarching goal of providing innovative and impactful medications to patients dealing with severe illnesses. The acquisition notably includes Horizon's pharmaceutical portfolio, encompassing Tepezza, designed to address thyroid eye disease, Krystexxa, targeting chronic refractory gout, and Uplizna, intended for neuromyelitis optica spectrum disorder.

Major companies operating in the biosimilar growth hormones market include Amega Biotech, Biosidus S.A., Eli Lilly and Company, Ferring Pharmaceuticals, Genetech Inc., Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Sanofi S.A., USV Private Limited, Zhongshan Hygene Biopharm Co. Ltd., Biopartners And LG Chem, Boehringer Ingelheim International GmbH, Celltrion Inc., Dr. Reddy's Laboratories Ltd., Gedeon Richter Plc., Genor Biopharma Co. Ltd., Hetero Drugs Limited, Intas Pharmaceuticals Ltd., LG Chem Ltd., Lupin Limited, Mabion S.A., Mundipharma International Limited, Panacea Biotec Limited, Pfenex Inc., PlantForm Corporation

North America was the largest region in the biosimilar growth hormone market in 2024. The Middle East is expected to be the fastest-growing region in the biosimilar growth hormones market report during the forecast period. The regions covered in the biosimilar growth hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the biosimilar growth hormones market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The biosimilar growth hormone market consists of sales of teriparatide, follitropin alfa, insulin, and somatropin. Values in this market are 'factory gate values,' that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biosimilar Growth Hormones Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biosimilar growth hormones market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biosimilar growth hormones ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biosimilar growth hormones market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Route Of Administration: Intravenous; Subcutaneous; Intramuscular; Oral
• 2) By Application: Growth Hormone Deficiency; Turner Syndrome; Idiopathic Short Stature; Prader Willi Syndrome; Other Applications
• 3) By Distribution Channel: Hospital And Retail Pharmacy; Online Pharmacy/ePharmacy; Specialty Clinics
• Subsegments:
• 1) By Intravenous: Hospital-based Administration; Outpatient Clinics
• 2) By Subcutaneous: Self-administration; Professional Administration
• 3) By Intramuscular: Pediatric Care; Adult Care
• 4) By Oral: Tablets; Capsules
• Companies Mentioned: Amega Biotech; Biosidus S.A.; Eli Lilly and Company; Ferring Pharmaceuticals; Genetech Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biosimilar Growth Hormones Market Characteristics

3. Biosimilar Growth Hormones Market Trends And Strategies

4. Biosimilar Growth Hormones Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Biosimilar Growth Hormones Growth Analysis And Strategic Analysis Framework

• 5.1. Global Biosimilar Growth Hormones PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Biosimilar Growth Hormones Market Growth Rate Analysis
• 5.4. Global Biosimilar Growth Hormones Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Biosimilar Growth Hormones Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Biosimilar Growth Hormones Total Addressable Market (TAM)

6. Biosimilar Growth Hormones Market Segmentation

• 6.1. Global Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous
• Subcutaneous
• Intramuscular
• Oral
• 6.2. Global Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Growth Hormone Deficiency
• Turner Syndrome
• Idiopathic Short Stature
• Prader Willi Syndrome
• Other Applications
• 6.3. Global Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital And Retail Pharmacy
• Online Pharmacy/ePharmacy
• Specialty Clinics
• 6.4. Global Biosimilar Growth Hormones Market, Sub-Segmentation Of Intravenous, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital-based Administration
• Outpatient Clinics
• 6.5. Global Biosimilar Growth Hormones Market, Sub-Segmentation Of Subcutaneous, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Self-administration
• Professional Administration
• 6.6. Global Biosimilar Growth Hormones Market, Sub-Segmentation Of Intramuscular, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pediatric Care
• Adult Care
• 6.7. Global Biosimilar Growth Hormones Market, Sub-Segmentation Of Oral, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules

7. Biosimilar Growth Hormones Market Regional And Country Analysis

• 7.1. Global Biosimilar Growth Hormones Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Biosimilar Growth Hormones Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biosimilar Growth Hormones Market

• 8.1. Asia-Pacific Biosimilar Growth Hormones Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biosimilar Growth Hormones Market

• 9.1. China Biosimilar Growth Hormones Market Overview
• 9.2. China Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biosimilar Growth Hormones Market

• 10.1. India Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biosimilar Growth Hormones Market

• 11.1. Japan Biosimilar Growth Hormones Market Overview
• 11.2. Japan Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biosimilar Growth Hormones Market

• 12.1. Australia Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biosimilar Growth Hormones Market

• 13.1. Indonesia Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biosimilar Growth Hormones Market

• 14.1. South Korea Biosimilar Growth Hormones Market Overview
• 14.2. South Korea Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biosimilar Growth Hormones Market

• 15.1. Western Europe Biosimilar Growth Hormones Market Overview
• 15.2. Western Europe Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biosimilar Growth Hormones Market

• 16.1. UK Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biosimilar Growth Hormones Market

• 17.1. Germany Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biosimilar Growth Hormones Market

• 18.1. France Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biosimilar Growth Hormones Market

• 19.1. Italy Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biosimilar Growth Hormones Market

• 20.1. Spain Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biosimilar Growth Hormones Market

• 21.1. Eastern Europe Biosimilar Growth Hormones Market Overview
• 21.2. Eastern Europe Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biosimilar Growth Hormones Market

• 22.1. Russia Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biosimilar Growth Hormones Market

• 23.1. North America Biosimilar Growth Hormones Market Overview
• 23.2. North America Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biosimilar Growth Hormones Market

• 24.1. USA Biosimilar Growth Hormones Market Overview
• 24.2. USA Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biosimilar Growth Hormones Market

• 25.1. Canada Biosimilar Growth Hormones Market Overview
• 25.2. Canada Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biosimilar Growth Hormones Market

• 26.1. South America Biosimilar Growth Hormones Market Overview
• 26.2. South America Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biosimilar Growth Hormones Market

• 27.1. Brazil Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biosimilar Growth Hormones Market

• 28.1. Middle East Biosimilar Growth Hormones Market Overview
• 28.2. Middle East Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biosimilar Growth Hormones Market

• 29.1. Africa Biosimilar Growth Hormones Market Overview
• 29.2. Africa Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biosimilar Growth Hormones Market Competitive Landscape And Company Profiles

• 30.1. Biosimilar Growth Hormones Market Competitive Landscape
• 30.2. Biosimilar Growth Hormones Market Company Profiles
  • 30.2.1. Amega Biotech Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Biosidus S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Ferring Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Genetech Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Biosimilar Growth Hormones Market Other Major And Innovative Companies

• 31.1. Merck & Co. Inc.
• 31.2. Novartis AG
• 31.3. Novo Nordisk A/S
• 31.4. Sanofi S.A.
• 31.5. USV Private Limited
• 31.6. Zhongshan Hygene Biopharm Co. Ltd.
• 31.7. Biopartners And LG Chem
• 31.8. Boehringer Ingelheim International GmbH
• 31.9. Celltrion Inc.
• 31.10. Coherus BioSciences Inc.
• 31.11. Daiichi Sankyo Company Ltd.
• 31.12. Dr. Reddy's Laboratories Ltd.
• 31.13. Gedeon Richter Plc.
• 31.14. Genor Biopharma Co. Ltd.
• 31.15. GenScript Biotech Corporation

32. Global Biosimilar Growth Hormones Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biosimilar Growth Hormones Market

34. Recent Developments In The Biosimilar Growth Hormones Market

35. Biosimilar Growth Hormones Market High Potential Countries, Segments and Strategies

• 35.1 Biosimilar Growth Hormones Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Biosimilar Growth Hormones Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Biosimilar Growth Hormones Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer